Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...
News-Medical.Net on MSN
Blocking two enzymes weakens prostate tumors and boosts drug effectiveness
A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for ...
Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...
Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists in Australia.
Two enzymes play a key role in prostate cancer growth and survival, and blocking them could help to boost the effectiveness of treatment.
Two enzymes from the protein disulphide isomerase (PDI) family enable prostate cancer cells to grow, survive, and resist ...
Scientists have identified two enzymes that help prostate cancer cells grow, survive and resist treatment, paving the way for new treatments.
Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists. A new ...
By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.
Researchers from Australia and China have found two enzymes that help cancer resist treatment. The experiments show that by ...
A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone ...
The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results